Ercros (ECR) - Total Liabilities
Based on the latest financial reports, Ercros (ECR) has total liabilities worth €396.07 Million EUR (≈ $463.05 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ercros - Total Liabilities Trend (2000–2025)
This chart illustrates how Ercros's total liabilities have evolved over time, based on quarterly financial data. See ECR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Ercros Competitors by Total Liabilities
The table below lists competitors of Ercros ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BLD Plantation Bhd
KLSE:5069
|
Malaysia | RM561.29 Million |
|
Regenxbio Inc
NASDAQ:RGNX
|
USA | $320.81 Million |
|
Accent Group Ltd
AU:AX1
|
Australia | AU$924.76 Million |
|
i3system Inc
KQ:214430
|
Korea | ₩52.25 Billion |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥736.45 Million |
|
Dogus Gayrimenkul Yatirim Ortakligi AS
IS:DGGYO
|
Turkey | TL6.46 Billion |
|
Bell Financial Group Ltd
AU:BFG
|
Australia | AU$866.82 Million |
|
Regional Management Corp
NYSE:RM
|
USA | $1.70 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Ercros's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ercros (ECR) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ercros's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ercros (2000–2025)
The table below shows the annual total liabilities of Ercros from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €396.07 Million ≈ $463.05 Million |
+10.62% |
| 2024-12-31 | €358.03 Million ≈ $418.58 Million |
+11.82% |
| 2023-12-31 | €320.20 Million ≈ $374.35 Million |
-17.01% |
| 2022-12-31 | €385.84 Million ≈ $451.09 Million |
+1.98% |
| 2021-12-31 | €378.34 Million ≈ $442.32 Million |
+23.64% |
| 2020-12-31 | €306.00 Million ≈ $357.75 Million |
-16.01% |
| 2019-12-31 | €364.33 Million ≈ $425.94 Million |
+9.11% |
| 2018-12-31 | €333.90 Million ≈ $390.37 Million |
-5.06% |
| 2017-12-31 | €351.68 Million ≈ $411.15 Million |
+3.33% |
| 2016-12-31 | €340.35 Million ≈ $397.90 Million |
+1.35% |
| 2015-12-31 | €335.80 Million ≈ $392.59 Million |
-4.75% |
| 2014-12-31 | €352.53 Million ≈ $412.14 Million |
-10.09% |
| 2013-12-31 | €392.08 Million ≈ $458.38 Million |
-9.10% |
| 2012-12-31 | €431.31 Million ≈ $504.25 Million |
+3.07% |
| 2011-12-31 | €418.45 Million ≈ $489.21 Million |
-3.69% |
| 2010-12-31 | €434.46 Million ≈ $507.93 Million |
-0.06% |
| 2009-12-31 | €434.72 Million ≈ $508.23 Million |
-3.36% |
| 2008-12-31 | €449.83 Million ≈ $525.90 Million |
-7.42% |
| 2007-12-31 | €485.89 Million ≈ $568.06 Million |
-24.76% |
| 2006-12-31 | €645.81 Million ≈ $755.02 Million |
+27.14% |
| 2005-12-31 | €507.94 Million ≈ $593.84 Million |
+90.38% |
| 2004-12-31 | €266.81 Million ≈ $311.93 Million |
+18.19% |
| 2003-12-31 | €225.75 Million ≈ $263.93 Million |
+16.04% |
| 2002-12-31 | €194.55 Million ≈ $227.45 Million |
-2.32% |
| 2001-12-31 | €199.17 Million ≈ $232.85 Million |
-99.44% |
| 2000-12-31 | €35.26 Billion ≈ $41.22 Billion |
-- |
About Ercros
Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl ch… Read more